Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Data presented at USCHA 2026 demonstrate that culturally-responsive campaigns significantly improve HIV PrEP awareness.

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...

A mobile retail pharmacy and clinic model in Connecticut improves HIV care and substance use treatment for vulnerable ...

Disparities in pre-exposure prophylaxis access and routine screening continue to hinder national efforts to prevent and treat ...

Oseltamivir reduces ICU admission risk and shortens hospital stays in pediatric patients hospitalized with influenza.

Previous STI history is linked to increased current PrEP use, though uptake disparities remain across patient demographic ...

Infectious Disease Advisor provides news updates and key opinion leader interviews from USCHA 2026, held in Anaheim, ...

Women living with HIV experience disproportionate clinical disparities and remain underrepresented in research and clinical ...

Researchers evaluated changes in inpatient all-cause pneumonia rates among US adults before and after the introduction of the 13-valent pneumococcal conjugate vaccine.

New legislative efforts seek to address housing instability and prevent discrimination against aging people living with HIV ...